HEMOTAG® Assessment for Short-term Outcomes of Heart Failure (HATS-OFF)
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure [HATS-OFF]
Sponsor: Aventusoft, LLC.
Listed as NCT04149743, this NA trial focuses on Heart Failure (HF) and remains actively recruiting participants. Sponsored by Aventusoft, LLC., it has been updated 6 times since 2022, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Sep 2023 — Jul 2024 [monthly]
Recruiting NA
-
Jun 2022 — Sep 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Jun 2022 [monthly]
Not Yet Recruiting NA
▶ Show 1 earlier version
-
Dec 2019 — Jan 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Aventusoft, LLC.
- Cleveland Clinic Florida
- National Heart, Lung, and Blood Institute (NHLBI)
For direct contact, visit the study record on ClinicalTrials.gov .